Find a TAVR Center
Free Info Kit
Doctor Discussion Guide

Share with friends

Close

TAVR Videos

Watch videos and hear real stories from people who have undergone transcatheter aortic valve replacement (TAVR).

Featured video

 

Mario Gets Back on His Game

Hard work helps you live longer! Even as he's gotten older and well after retirement, Mario has lived by that motto and remained "on the go". As his aortic stenosis symptoms progressed, he had no choice but to slow down though. Due to previous bypass surgery and other risk factors, TAVR was recommended as the best option for him. Since his procedure, Mario is back to being active and busy, which is just the way he and his family like it-- whether keeping up with his grandchildren, remaining involved in a family business, or, meeting his friends on the golf green.


TAVR Basics

  • Your Path to Treatment

    If you have been diagnosed with Severe Aortic Stenosis, this video helps explain how to get treated.

  • Talking to your Doctor about Severe Aortic Stenosis

    If you've been diagnosed with severe aortic stenosis, an important first step is to have an open and honest conversation with your doctor (either your primary care physician or your cardiologist), so you feel informed and involved in your treatment decisions. Show more

  • Treatment Options for Severe Aortic Stenosis

    Watch this video to learn about the treatment options for your severe aortic stenosis.

  • How Does Transcatheter Aortic Valve Replacement (TAVR) Work?

    Watch this video to learn how transcatheter aortic valve replacement (TAVR) works.

  • Getting to Know Your Heart Team

    Talking to a Heart Team ensures you have the best understanding of your severe aortic stenosis plan.

Procedure Videos

  • Transfemoral Approach

  • Transapical Approach

  • Transaortic Approach

Patient Videos

Meet each person and hear what they are saying about their experiences and life after their procedure.

  • Mario Gets Back on His Game

    Hard work helps you live longer! Even as he's gotten older and well after retirement, Mario has lived by that motto and remained "on the go". As his aortic stenosis symptoms progressed, he had no choice but to slow down though. Due to previous bypass surgery and other risk factors, TAVR was recommended as the best option for him. Since his procedure, Mario is back to being active and busy, which is just the way he and his family like it-- whether keeping up with his grandchildren, remaining involved in a family business, or, meeting his friends on the golf green. Show more

  • Evelyn’s Winning Attitude Towards Life is Renewed

    Evelyn has lived up to her reputation as "the Energizer Bunny" all her life. Her daughters became very concerned when her severe aortic stenosis really started slowing her down to the point where she passed out a few times. Based on her age and other risk factors, TAVR was recommended as the best option for Evelyn whose family is back to trying to keep up with her… especially when she's trying her luck at the local casino! Show more

  • Former Selma, AL Police Chief Gets His Life Back

    Earnest Tate, the first African-American chief of police in Selma, AL has always been very strong and independent, a pillar in his community. His family was extremely concerned as he began to rapidly deteriorate right before their eyes. Surrounded by a team of specialists who detected his severe aortic stenosis and recognized the urgency, Chief Tate got the TAVR procedure he needed just in time. Today he feels blessed to have his life back! Be inspired by Chief Tate’s reflections on his life and his TAVR journey. Show more

  • Through The Eyes of a Caregiver

    As Orville experienced the symptoms of aortic stenosis, his wife Beverly was by his side every step of the way. Listen as these two recount Orville's journey from symptoms to treatment options, and how both patient and caregiver felt about his transcatheter aortic valve replacement procedure. Show more

  • Grandpa's TAVR Journey

    David (aka “Grandpa”) and his family share their perspectives on his TAVR treatment journey from diagnosis through recovery. His daughter-in-law, Mary, offers some important reflections and considerations for those caring for a loved one with aortic stenosis. Show more

  • World War II POW and Hero Gets a New Valve

    Suffering from severe aortic stenosis, but not a candidate for open heart surgery, Lester received TAVR, allowing him to see a day he never thought possible. Show more

  • A True Cowboy Rides Again with Aortic Valve Replacement Using TAVR

    Hit with the reality of severe aortic stenosis symptoms, Jake's age and medical history prevented him from receiving open heart surgery. Thanks to his heart specialists, he underwent TAVR and is so grateful to have his cowboy life back. Show more

  • Un Vaquero Verdadera Monta Otra Vez con Reemplazo Valvular Aórtico Usando TAVR

    Hit con la realidad de los síntomas graves de estenosis aórtica , de la edad y los antecedentes médicos Jake le impidió recibir la cirugía a corazón abierto. Gracias a sus especialistas del corazón , se sometió a TAVR y está tan agradecida de tener su vida de vaquero espalda. Show more

  • With TAVR, Breast Cancer Survivor Conquers a New Battle of Aortic Stenosis

    Sandy, a proud breast cancer survivor, learned she had aortic stenosis and was not a candidate for traditional open heart surgery. She refused to give up and soon discovered TAVR as an alternative option–improving her condition and lifting her spirits. Show more

  • Experience Lois' Journey Through TAVR

    Lois, a throat cancer survivor, was at high risk for surgery but needed an aortic valve replacement Watch her experience and the integral part her Heart Team played in her care. Show more

Important Risk Information

Indications: The Edwards SAPIEN 3 transcatheter heart valve (THV), model 9600TFX, and accessories are indicated for relief of aortic stenosis in patients with symptomatic heart disease...

  • Important Risk Information for Patients

    EDWARDS SAPIEN 3 TRANSCATHETER HEART VALVE

    Indications: The Edwards SAPIEN 3 transcatheter heart valve, model 9600TFX, and accessories are indicated for relief of aortic stenosis in patients with symptomatic heart disease due to severe native calcific aortic stenosis who are judged by a Heart Team, including a cardiac surgeon, to be at intermediate or greater risk for open surgical therapy (i.e., predicted risk of surgical mortality ≥ 3% at 30 days, based on the Society of Thoracic Surgeons (STS) risk score and other clinical co-morbidities unmeasured by the STS risk calculator).

    Contraindications (Who should not use): The Edwards SAPIEN 3 transcatheter heart valve and delivery system should not be used in patients who:

    • Cannot tolerate medications that thin the blood or prevent blood clots from forming.
    • Have an active infection in the heart or elsewhere.

    Warnings:

    • There may be an increased risk of stroke in transcatheter aortic valve replacement procedures, compared to other standard treatments for aortic stenosis in the high or greater risk population.
    • If an incorrect valve size for your anatomy is used, it may lead to heart injury, valve leakage, movement, or dislodgement.
    • Patients should talk to their doctor if they have significant heart disease, a mitral valve device or are allergic to chromium, nickel, molybdenum, manganese, copper, silicon, and/or polymeric materials.
    • The SAPIEN 3 valve may not last as long in patients whose bodies do not process calcium normally.
    • During the procedure, your doctors should monitor the dye used in the body; if used in excess it could lead to kidney damage. X-ray guidance used during the procedure may cause injury to the skin, which may be painful, damaging, and long-lasting.
    • Transcatheter aortic heart valve patients should take medications that thin the blood or prevent blood clots from forming, except when likely to have an adverse reaction, as determined by their physician. The Edwards SAPIEN 3 transcatheter heart valve has not been tested for use without medications that thin the blood or prevent blood clots from forming.

    Precautions: The long-term durability of the Edwards SAPIEN 3 transcatheter heart valve is not known, at this time. Regular medical follow-up is recommended to evaluate how well a patient’s heart valve is performing. For patients who have previously had aortic valve replacement, the safety, effectiveness, and durability of putting a transcatheter valve in an already implanted artificial valve are not known at this time.

    The safety and effectiveness of the transcatheter heart valve is also not known for patients who have:

    • An aortic heart valve that is not calcified, contains only one or two leaflets, has leaflets with large pieces of calcium that may block the vessels that supply blood to the heart or in which the main problem is that the valve leaks
    • Previous heart valve replacement or repair
    • A heart that does not pump well, has thickening of the heart muscle, with or without blockage, unusual ultrasound images of the heart that could represent irregularities such as a blood clot, a diseased mitral valve that is calcified or leaking, or Gorlin syndrome, a condition that affects many areas of the body and increases the risk of developing various cancers and tumors
    • Low white, red or platelet blood cell counts, or history of bleeding because the blood does not clot properly
    • Diseased or irregularly shaped vessels leading to the heart. Vessels in the legs which are heavily diseased or too small for associated delivery devices, or a large amount of calcification at the point of entry to the heart
    • Allergies to blood-thinning medications or dye injected during the procedure

    Potential risks associated with the procedure include:

    • Death, stroke, paralysis (loss of muscle function), permanent disability, or severe bleeding
    • Risks to the heart, including heart attack or heart failure, a heart that does not pump well, irregular heartbeat that may result in a need for a permanent pacemaker, chest pain, heart murmur, false aneurysm, recurring aortic stenosis(narrowing), too much fluid around the heart
    • Risks to your lungs or breathing, including difficulty breathing, fainting, buildup of fluid in or around the lungs, weakness or inability to exercise
    • Risks involving bleeding or your blood supply, including formation of a blood clot, high or low blood pressure, limited blood supply, a decrease in red blood cells, or abnormal lab values, bleeding in the abdominal cavity, collection of blood under the skin
    • Additional risks, including life-threatening infection, dislodgement of calcified material, air embolism (air bubbles in the blood vessels), poor kidney function or failure, nerve injury, fever, allergic reaction to anesthesia or dye, reoperation, pain, infection or bleeding at incision sites, or swelling

    Additional potential risks specifically associated with the use of the heart valve include:

    • Valve movement after deployment, blockage or disruption of blood flow through the heart, need for additional heart surgery and possible removal of the SAPIEN 3 valve, a blood clot that requires treatment, damage to the valve (e.g., wear, breakage, recurring aortic stenosis), nonstructural valve dysfunction (e.g., leakage, inappropriate sizing or positioning, blockage, excess tissue in growth, blood cell damage, etc.) or mechanical failure of the delivery system and/or accessories
  • EDWARDS SAPIEN XT TRANSCATHETER HEART VALVE

    Indications: The Edwards SAPIEN XT transcatheter heart valve, model 9300TFX, and accessories are indicated for relief of aortic stenosis in patients with symptomatic heart disease due to severe native calcific aortic stenosis who are judged by a Heart Team, including a cardiac surgeon, to be at intermediate or greater risk for open surgical therapy (i.e., predicted risk of surgical mortality ≥ 3% at 30 days, based on the Society of Thoracic Surgeons (STS) risk score and other clinical co-morbidities unmeasured by the STS risk calculator).

    The Edwards SAPIEN XT transcatheter heart valve and accessories are also indicated for patients with symptomatic heart disease due to failure (stenosed, insufficient, or combined) of a surgical bioprosthetic aortic valve who are judged by a heart team, including a cardiac surgeon, to be at high or greater risk for open surgical therapy (i.e., STS operative risk score ≥8% or at a ≥15% risk of mortality at 30 days).

    Contraindications (Who should not use): The Edwards SAPIEN XT transcatheter heart valve and delivery systems should not be used in patients who:

    • Cannot tolerate medications that thin the blood or prevent blood clots from forming.
    • Have an active infection in the heart or elsewhere.

    Warnings:

    • There is a higher risk of stroke in transcatheter aortic valve replacement procedures, compared to balloon aortic valvuloplasty and other standard treatments for aortic stenosis in the high or greater risk population.
    • Implanting a valve that is too small may cause blood leakage and valve movement. Implanting a valve that is too large can cause a buildup of pressure in the valve or a rupture of blood vessels in or around your heart. Your Heart Team will do tests to determine the best valve size for you.
    • The SAPIEN XT valve may not last as long in patients whose bodies do not process calcium normally.
    • Patients should talk to their doctor if they have significant heart disease, a mitral valve device or are allergic to chromium, nickel, molybdenum, manganese, copper, silicon, and/or polymeric materials.
    • During the procedure, your doctors should monitor the dye used in the body; if used in excess it could lead to kidney damage. X-ray guidance used during the procedure may cause injury to the skin, which may be painful, damaging, and long-lasting.
    • Transcatheter aortic heart valve patients should take medications that thin the blood or prevent blood clots from forming, except when likely to have an adverse reaction, as determined by their physician. The Edwards SAPIEN XT transcatheter heart valve has not been tested for use without medications that thin the blood or prevent blood clots from forming.

    Precautions: The long-term durability of the Edwards SAPIEN XT transcatheter heart valve is not known, at this time. Regular medical follow-up is recommended to evaluate how well a patient’s heart valve is performing.

    The safety and effectiveness of implanting:

    • A transcatheter valve inside a transcatheter valve is not known
    • A transcatheter valve inside a surgical tissue valve is not known in the intermediate-risk population

    The safety and effectiveness of the transcatheter heart valve is also not known for patients who have:

    • An aortic heart valve that is not calcified, contains only one or two leaflets, has leaflets with large pieces of calcium that may block the vessels that supply blood to the heart or in which the main problem is that the valve leaks.
    • Previous heart valve replacement or repair
    • A heart that does not pump well, has thickening of the heart muscle, with or without blockage, unusual ultrasound images of the heart that could represent irregularities such as a blood clot, a diseased mitral valve that is calcified or leaking, or Gorlin syndrome, a condition that affects many areas of the body and increases the risk of developing various cancers and tumors
    • Low white, red or platelet blood cell counts, or history of bleeding because the blood does not clot properly
    • Diseased or irregularly shaped vessels leading to the heart. Vessels in the legs which are heavily diseased or too small for associated delivery devices, or a large amount of calcification at the point of entry to the heart, depending on delivery method
    • Allergies to blood-thinning medications or dye injected during the procedure

    Potential risks associated with the procedure include:

    • Death, stroke, paralysis (loss of muscle function), permanent disability, or severe bleeding
    • Risks to the heart, including heart attack or heart failure, a heart that does not pump well, irregular heartbeat that may result in a need for a permanent pace maker, chest pain, heart murmur, false aneurysm, recurring aortic stenosis(narrowing), too much fluid around the heart
    • Risks to your lungs or breathing, including difficulty breathing, fainting, buildup of fluid in or around the lungs, weakness or inability to exercise
    • Risks involving bleeding or your blood supply, including formation of a blood clot, high or low blood pressure, limited blood supply, a decrease in red blood cells, or abnormal lab values, bleeding in the abdominal cavity, collection of blood under the skin
    • Additional risks, including life-threatening infection, dislodgement of calcified material, air embolism (air bubbles in the blood vessels), poor kidney function or failure, nerve injury, fever, allergic reaction to anesthesia or dye, reoperation, pain, infection or bleeding at incision sites, or swelling
    • For a valve in valve procedure, there is a risk of leakage if the previously implanted tissue valve is not securely in place or if it is damaged. There is also the possibility that a partially detached valve leaflet from the previously implanted valve could block a blood vessel. The safety and effectiveness of the transcatheter heart valve has not been determined when the valve is implanted:
      • Inside a stented previously implanted valve smaller than 21 mm
      • Inside an unstented previously implanted aortic tissue valve
    • Your Heart Team will do tests to determine the exact size of the new valve you should receive and communicate what to expect.

    Additional potential risks specifically associated with the use of the heart valve include:

    • Valve movement after deployment, blockage or disruption of blood flow through the heart, sudden loss of heart function, heart failure, need for additional heart surgery and possible removal of the SAPIEN XT valve, a blood clot that requires treatment, damage to the valve (e.g., wear, breakage, recurring aortic stenosis), nonstructural valve dysfunction (e.g., leakage, inappropriate sizing or positioning, blockage, excess tissue ingrowth, blood cell damage, etc.) or mechanical failure of the delivery system and/or accessories

    Be sure to ask your Heart Team to explain your treatment options and the possible benefits and risks of the procedure.

    CAUTION: Federal law (USA) restricts these devices to sale by or on the order of a physician. This information is not a substitute for talking with your doctor.

    Edwards, Edwards Lifesciences, the stylized E logo, Edwards SAPIEN, Edwards SAPIEN XT, Edwards SAPIEN 3, NewHeartValve.com, NewHeartValve.com design logo, SAPIEN, SAPIEN XT, and SAPIEN 3 are trademarks of Edwards Lifesciences Corporation. All other trademarks are the property of their respective owners.

    © 2016 Edwards Lifesciences Corporation. All rights reserved.